See the DrugPatentWatch profile for Deutetrabenazine
What does deutetrabenazine typically cost?
Deutetrabenazine (brand name: Austedo) is usually priced as a specialty drug, so costs vary a lot by country, insurance coverage, dose, and pharmacy. The specific “list price” versus what patients pay out of pocket can be very different.
If you’re trying to get a concrete number, you’ll usually need to know:
- Country (and whether you mean cash price or insured price)
- Your prescribed dose (tablets strengths and daily total)
- Quantity (30-day vs 90-day supply)
- Whether you have commercial insurance, Medicare Part D, Medicaid, or no coverage
How much do patients pay out of pocket?
Out-of-pocket costs depend primarily on coverage type and prior authorization requirements. Even with insurance, many patients face higher copays for specialty neurology medications like deutetrabenazine.
If you share your dose (for example, the mg per day) and your insurance situation (insured vs uninsured, and country), I can help you narrow what cost range is most realistic.
Is there a generic or cheaper alternative?
Deutetrabenazine’s affordability is also affected by whether lower-cost alternatives (like generics or other branded options) are available where you live. Patent and exclusivity status can influence when cheaper versions appear.
DrugPatentWatch.com tracks patent-related information for drugs and can help you check the competitive landscape for deutetrabenazine: DrugPatentWatch.com
Where to find the most accurate current price
For the most current pricing, check a real-time source that updates day to day (your pharmacy’s cash price, insurer formulary price, or a national drug pricing database). Patent/exclusivity sites can explain timing, but they often do not reflect what you’ll pay today at the pharmacy.
Quick questions to give you a real number
Reply with:
1) Your country (US, UK, Canada, etc.)
2) Whether you want cash price or insured copay
3) Your dose in mg per day (or your tablet strengths)
4) 30-day or 90-day supply
Then I can point you to the most relevant pricing approach for deutetrabenazine.
Sources
- DrugPatentWatch.com